Stocks · Korea 302550 KOSDAQ

Remed

2,635원 +2.73% Market cap 798억 2026-10-07 close
Data as of 2026-10-07 · Linked from 7 pages
An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER155.00x
PBR2.03x
EPS17 KRW
BPS1,296 KRW
ROE1.95%
DPS0 KRW

Returns and 52-week range

1W-1.68%
1M-0.57%
3M-3.48%
6M-13.75%
1Y-29.73%
YTD-12.89%
52W high4,070원
52W low2,300원
From 52W high-35.26%

Financial results (consolidated)

PeriodRevenueOperating incomeNet incomeOP margin
2022214억17억40억7.8%
2023185억-29억3억-15.4%
2024256억11억74억4.4%
2025245억7억-35,468,721원3.0%
Quarterly
2024 4Q64억-3억31억-3.9%
2025 1Q64억4억2억5.8%
2025 2Q56억24,896,013원-2억0.5%
2025 3Q58억3억2억4.7%
2025 4Q67억51,350,278원-2억0.8%
2026 1Q72억7억10억9.5%

Company

CEO이근용
Founded2003-07-31
Fiscal year end12
Websiteremed.kr
Address: 충청북도 청주시 흥덕구 오송읍 오송생명2로 84 -

Peers in the same sector

CompanyMarket capP/EP/B1M
피엠티807억—6.02+31.01%
휴비츠788억—0.72+2.70%
피제이전자853억9.130.61+23.66%
코렌텍783억11.941.00+46.18%
오스테오닉868억11.231.25+0.12%
하이로닉778억21.051.04-6.51%

Recent filings

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.